Caricamento...
Interleukin-35 limits anti-tumor immunity
Regulatory T (Treg) cells pose a major barrier to effective anti-tumor immunity. Although Treg cell depletion enhances tumor rejection, the ensuing autoimmune sequelae limits its utility in the clinic and highlights the need for limiting Treg cell activity within the tumor microenvironment. Interleu...
Salvato in:
| Pubblicato in: | Immunity |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758699/ https://ncbi.nlm.nih.gov/pubmed/26872697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2016.01.013 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|